Daxor Corporation (DXR)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Daxor Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Daxor Corporation (DXR) has returned -34.44% so far this year and 19.09% over the past 12 months. Over the last ten years, DXR has returned 2.09% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Mar 17, 1992, DXR's average daily return is +0.08%, while the average monthly return is +1.40%. At this rate, your investment would double in approximately 4.2 years.

Historically, 43% of months were positive and 57% were negative. The best month was Mar 2018 with a return of +166.1%, while the worst month was Aug 1992 at -50.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, DXR closed higher 39% of trading days. The best single day was Oct 30, 2018 with a return of +86.8%, while the worst single day was Aug 6, 1992 at -25.8%.

Daxor Corporation has an annualized alpha of 19.46%, beta of 0.18, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 18, 1992.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (32.68%) than losses (28.99%) — typical of diversified or defensive assets.
• Beta of 0.18 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

DXR ranks 54 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Daxor Corporation (DXR) and compare them to a chosen benchmark (S&P 500 Index).

Daxor Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Daxor Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Daxor Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Daxor Corporation was 82.59%, occurring on Mar 2, 2018. Recovery took 598 trading sessions.

The current Daxor Corporation drawdown is 59.34%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Daxor Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Daxor Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.